Verification evidence is still being completed.
PDF / print export
InfiCure Bio
Umea, Sweden
- Verified lead
- Sofia Mayans
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Co-Founder and Chief Executive Officer
- 2026 technical specialization
- Preclinical CRO, Anti-Fibrotic In Vivo Efficacy, and Chronic Inflammation Models
- Review cycle
- 24 April 2026
- Full address
- Tvistevagen 48C, 907 36 Umea, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Crunchbase profile listing Sofia Mayans as Founder and CEO of InfiCure Bio.
- Editorial note
- Umea preclinical CRO with a named founder-CEO, a proprietary NIF mouse model for fibrosis and chronic inflammation, and an InnoSer international distribution partnership.
Preclinical CRO, Anti-Fibrotic In Vivo Efficacy, and Chronic Inflammation Models
Crunchbase leadership listing, Umea Biotech Incubator coverage, InnoSer international distribution partnership
Umea preclinical CRO with a named founder-CEO, a proprietary NIF mouse model for fibrosis and chronic inflammation, and an InnoSer international distribution partnership.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Umea preclinical CRO with a named founder-CEO, a proprietary NIF mouse model for fibrosis and chronic inflammation, and an InnoSer international distribution partnership.
Contact & location
- Website
- inficurebio.com
- Company page
- Lead
- Sofia Mayans (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Preclinical contract research
- Capabilities
- NIF Mouse Model Studies · Anti-Fibrotic and Anti-Inflammatory Efficacy Testing · Histopathology Readouts
- Founded
- 2018
- Headcount
- 1-10
Clinical profileSTATUS: VERIFIED APRIL 2026
Sofia Mayans
Co-Founder and Chief Executive Officer
Full addressTvistevagen 48C, 907 36 Umea, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Preclinical contract research
Umea, Sweden. Preclinical CRO, Anti-Fibrotic In Vivo Efficacy, and Chronic Inflammation Models. Review completed on 24 Apr 2026.
Swedish authorities for animal research and preclinical study ethics
Crunchbase leadership listing, Umea Biotech Incubator coverage, InnoSer international distribution partnership
Preclinical CRO, Anti-Fibrotic In Vivo Efficacy, and Chronic Inflammation Models
Umea preclinical CRO with a named founder-CEO, a proprietary NIF mouse model for fibrosis and chronic inflammation, and an InnoSer international distribution partnership.
Editorial note
InfiCure Bio is a small-team Umea CRO with a proprietary NIF mouse model of spontaneous chronic inflammation and multi-organ fibrosis, useful for anti-fibrotic and MASH program sponsors looking for differentiated in vivo readouts.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
NIF Mouse Model Studies
Anti-Fibrotic and Anti-Inflammatory Efficacy Testing
Histopathology Readouts
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
NIF mouse colony
Histopathology workflow
In vivo disease-progression readouts
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is InfiCure Bio located?
- InfiCure Bio operates from Tvistevagen 48C, 907 36 Umea, Sweden, Umea, Sweden.
- Who runs InfiCure Bio?
- InfiCure Bio is led by Sofia Mayans, Co-Founder and Chief Executive Officer. Verified 24 Apr 2026.
- What does InfiCure Bio do?
- Umea preclinical CRO with a named founder-CEO, a proprietary NIF mouse model for fibrosis and chronic inflammation, and an InnoSer international distribution partnership. Core capabilities: NIF Mouse Model Studies, Anti-Fibrotic and Anti-Inflammatory Efficacy Testing, Histopathology Readouts.
Editorial context
Related technical briefs
Briefs that name Umea as a covered market or city.